Pekka Jäkälä
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pekka Jäkälä has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aino Rönkä
Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland Kuopio Finland
1 shared publication - Eila Sonkajärvi
Department of Anesthesiology, University of Oulu, Oulu University Hospital, Oulu, Finland
1 shared publication - Hanne Kuitunen
Medical Research Center Oulu, Oulu University Hospital, University of Oulu, 90220 Oulu, Finland
1 shared publication - Inka Puhakka
Department of Neurology, Kuopio University Hospital, Kuopio, Finland
1 shared publication - Miika Korhonen
ORCID http://orcid.org
1 shared publication - Outi M. Kuittinen
Department of Oncology and Radiotherapy, Kuopio University Hospital, 70210 Kuopio, Finland
1 shared publication
Latest Publications
- Open Access
- 3 March 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-8
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
Background: We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. Methods: Finnish Cancer Registry data by histological diagnosis and tumor location (2007–2017) for cases with diffuse large B-cell lymphoma. Results: During 2007–2017, 392 new cases of PCNSL were reported (195 males, 197 females). The average age-adjusted incidence was 0.68/100,000 person-years. Incidence for males was 0.74/100,000 and for females 0.63/100,000, respectively. The incidence was highest, 2.93/100,000, among people aged 75–79 years. Concerning all cases in 2007–2017 the 2-year age-adjusted relative survival rate was 33% and the corresponding 5-year survival rate was 26%. Among patients under the age of 70, the age-adjusted 5-year relative survival rate increased from 36% in 2007–2012 to 43% for 2013–2017. Among patients aged 70+ the corresponding survival rates were poor, 7 and 9%. Conclusions: PCNSL incidence in Finland is among the highest reported in the world. The annual increase in incidence was 2.4%. The prognosis is still dismal, especially in elderly patients.
- 3 March 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-8
Open AccessPrimary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
Background: We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. Methods: Finnish Cancer Registry data by histological diagnosis and tumor location (2007–2017) for cases with diffuse large B-cell lymphoma. Results: During 2007–2017, 392 new cases of PCNSL were reported (195 males, 197 females). The average age-adjusted incidence was 0.68/100,000 person-years. Incidence for males was 0.74/100,000 and for females 0.63/100,000, respectively. The incidence was highest, 2.93/100,000, among people aged 75–79 years. Concerning all cases in 2007–2017 the 2-year age-adjusted relative survival rate was 33% and the corresponding 5-year survival rate was 26%. Among patients under the age of 70, the age-adjusted 5-year relative survival rate increased from 36% in 2007–2012 to 43% for 2013–2017. Among patients aged 70+ the corresponding survival rates were poor, 7 and 9%. Conclusions: PCNSL incidence in Finland is among the highest reported in the world. The annual increase in incidence was 2.4%. The prognosis is still dismal, especially in elderly patients.